Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

FTC (Emtriva) approved.

John S James

    AIDS Treatment News
    |December 19, 2003
    PubMed
    Summary
    This summary is machine-generated.

    A new antiretroviral drug, the 19th approved in the U.S., is now available. This medication is chemically related to 3TC, offering a new treatment option.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Activism and online fundraising: overview.

    AIDS treatment news·2007
    Same author

    "Fundathon": toward massively multiplayer online fundraising games.

    AIDS treatment news·2007
    Same authorSame journal

    Selling digital art in bulk through prepaid URLs.

    AIDS treatment news·2007
    Same authorSame journal

    Financial accounts that can reproduce, inherit, and evolve.

    AIDS treatment news·2007
    Same authorSame journal

    AIDS search engine wanted: what to do now?

    AIDS treatment news·2007
    Same author

    Prisoner death rate very high immediately after release.

    AIDS treatment news·2007
    Same journal

    New kind of antiretroviral, KP-1461; clinical trial recruiting. Interview with Stephen Becker, M.D.

    AIDS treatment news·2008
    Same journal

    Flu shot reminder.

    AIDS treatment news·2008
    Same journal

    Is cure possible for HIV?

    AIDS treatment news·2007
    See all related articles

    Area of Science:

    • Pharmacology
    • Infectious Diseases
    • Drug Development

    Background:

    • A new antiretroviral medication has received U.S. approval.
    • This marks the 19th antiretroviral drug approved for use in the United States.

    Discussion:

    • The newly approved antiretroviral is chemically similar to 3TC.
    • This structural similarity may inform its mechanism of action and therapeutic potential.

    Key Insights:

    • The U.S. Food and Drug Administration (FDA) approved a novel antiretroviral agent on July 2nd.
    • This approval expands the armamentarium for treating viral infections, specifically HIV/AIDS.

    Outlook:

    • Further research will elucidate the specific efficacy and safety profile of this new agent.
    • Its relationship to 3TC may guide clinical decisions in combination therapy regimens.